New Investigational Vaccine Protects Mice From CCP Virus in Clinical Trial

This March 16, 2020 file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for the Chinese Communist Party virus, at the Kaiser Permanente Washington Health Research Institute in Seattle. Ted S. Warren/AP Photo

The National Institute of Allergy and Infectious Diseases (NIAID) has come up with an investigational vaccine for the CCP (Chinese Communist Party) virus and it protects mice from the infection.

“New data shows mRNA-1273, an investigational vaccine developed by #NIAID and @moderna_tx, protects mice from infection with #SARSCoV2,” NIAID said in a message on Twitter on June 12.